Related Experiment Video
Updated: Jun 3, 2026
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Review of tools of cardiovascular disease risk stratification: interpretation, customisation and application in
1Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia. chiayc@um.edu.my
Insights
Cardiovascular Disease (CVD) risk estimation is crucial for individuals with moderately abnormal factors. Utilizing appropriate risk assessment tools helps guide treatment decisions for better patient outcomes.
Area of Science:
- Cardiology
- Public Health
- Preventive Medicine
Background:
- Cardiovascular Disease (CVD) is a primary global cause of mortality.
- Accurate risk stratification is challenging for individuals with intermediate risk factors, who contribute significantly to the overall CVD burden.
- Existing CVD risk assessment tools have limitations and may not be universally applicable.
Purpose of the Study:
- To highlight the necessity of CVD risk estimation.
- To discuss the advantages and disadvantages of various risk assessment tools.
- To emphasize the importance of selecting appropriate tools for local populations and guiding treatment.
Main Methods:
- Review of existing Cardiovascular Disease risk assessment methodologies.
- Analysis of the applicability and limitations of current risk scores.
- Discussion on the ideal development of country-specific risk scores.
Main Results:
- No single risk score is universally perfect; each has inherent strengths and weaknesses.
- Risk assessment tools may require adaptation for local populations.
- Familiarity with and appropriate selection of a risk score are vital for clinical practice.
Conclusions:
- Accurate Cardiovascular Disease risk assessment is essential for managing the large group of patients with intermediate risk.
- Clinicians should be aware of the limitations of existing tools and select the most appropriate one for their patients.
- Tailoring risk assessment to local populations and discussing treatment based on estimated risk are key to improving cardiovascular health outcomes.
Abstract:
Cardiovascular Disease (CVD) is the leading cause of death in both developed and developing countries. While it is relatively easy to identify those who are obviously at high risk and those at the lowest risk for CVD, it is often the large group of individuals with what appears to be modestly abnormal risk factors who contributes most to the burden of CVD. This is where estimation of CVD risk is necessary. Many tools for risk assessment have been devised. All these risk scores have their own inherent advantages and disadvantages. Furthermore, they may also not be directly applicable to a local population. Ideally, each country should have its own risk score that takes into account other factors as well. In the interim, it is worthwhile to be familiar with one of these scores, select one that is most appropriate for your patient and discuss treatment options based on the estimated risk.
Related Concept Videos
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
01:30Coronary Artery Disease I: Introduction
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Atherosclerosis III: Management